Life Science Angels

Life Science Angels

Xconomy

FDA Refuses to Review Zogenix Seizure Drug, Says File Not Complete

$30,000,000 Venture capital (Series B)
FinSMEs , PE HUB

Mission Bio Raises $30M in Series B Funding

FinSMEs

Portfolia Funds Closes FemTech Fund with 249 Investors

PE HUB

Portfolia Funds rolls out sixth fund

Funding Technology
Seed fund
vcaonline

Venture Capital Access Online | Venture Capital News

PE HUB

Life Science Angels funds Mission Bio

Messaging
The Motley Fool

Zogenix, Inc. Shares Galloped 15% Higher in February -- Here's Why

Health Stock markets
The Motley Fool

Zogenix, Inc Gained 29% in 2015 -- Here's Why --

Stock markets
The Motley Fool

Zogenix Zoomed Higher in November -- Here's Why --

Stock markets Health Earnings